An interesting question arose in our study was whether dysregulation of glucose metabolism, lipid accumulation, inflammation, and fibrosis caused by STAT3 activation were limited to the MASH stage, since STAT3 plays different roles in different liver diseases or stages. The gene discussed is STAT3; the disease is liver disorder.